Literature DB >> 22622228

Updating the RNA polymerase CTD code: adding gene-specific layers.

Sylvain Egloff1, Martin Dienstbier, Shona Murphy.   

Abstract

The carboxyl-terminal domain (CTD) of RNA polymerase (pol) II comprises multiple tandem repeats with the consensus sequence Tyr(1)-Ser(2)-Pro(3)-Thr(4)-Ser(5)-Pro(6)-Ser(7) that can be extensively and reversibly modified in vivo. CTD modifications orchestrate the interplay between transcription and processing of mRNA. Although phosphorylation of Ser2 (Ser2P) and Ser5 (Ser5P) residues has been described as being essential for the expression of most pol II-transcribed genes, recent findings highlight gene-specific effects of newly discovered CTD modifications. Here, we incorporate these latest findings in an updated review of the currently known elements that contribute to the CTD code and how it is recognized by proteins involved in transcription and RNA maturation. As modification of the CTD has a major impact on gene expression, a better understanding of the CTD code is integral to the understanding of how gene expression is regulated.
Copyright © 2012 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22622228     DOI: 10.1016/j.tig.2012.03.007

Source DB:  PubMed          Journal:  Trends Genet        ISSN: 0168-9525            Impact factor:   11.639


  97 in total

Review 1.  The RNA polymerase II CTD "orphan" residues: Emerging insights into the functions of Tyr-1, Thr-4, and Ser-7.

Authors:  Nathan M Yurko; James L Manley
Journal:  Transcription       Date:  2017-10-04

Review 2.  Pause, play, repeat: CDKs push RNAP II's buttons.

Authors:  Miriam Sansó; Robert P Fisher
Journal:  Transcription       Date:  2013-06-11

Review 3.  RNA polymerase II C-terminal domain: Tethering transcription to transcript and template.

Authors:  Jeffry L Corden
Journal:  Chem Rev       Date:  2013-09-16       Impact factor: 60.622

4.  Genome-wide targeting of the epigenetic regulatory protein CTCF to gene promoters by the transcription factor TFII-I.

Authors:  Rodrigo Peña-Hernández; Maud Marques; Khalid Hilmi; Teijun Zhao; Amine Saad; Moulay A Alaoui-Jamali; Sonia V del Rincon; Todd Ashworth; Ananda L Roy; Beverly M Emerson; Michael Witcher
Journal:  Proc Natl Acad Sci U S A       Date:  2015-02-02       Impact factor: 11.205

5.  RNA Polymerase II Regulates Topoisomerase 1 Activity to Favor Efficient Transcription.

Authors:  Laura Baranello; Damian Wojtowicz; Kairong Cui; Ballachanda N Devaiah; Hye-Jung Chung; Ka Yim Chan-Salis; Rajarshi Guha; Kelli Wilson; Xiaohu Zhang; Hongliang Zhang; Jason Piotrowski; Craig J Thomas; Dinah S Singer; B Franklin Pugh; Yves Pommier; Teresa M Przytycka; Fedor Kouzine; Brian A Lewis; Keji Zhao; David Levens
Journal:  Cell       Date:  2016-04-07       Impact factor: 41.582

6.  Enhancer RNA facilitates NELF release from immediate early genes.

Authors:  Katie Schaukowitch; Jae-Yeol Joo; Xihui Liu; Jonathan K Watts; Carlos Martinez; Tae-Kyung Kim
Journal:  Mol Cell       Date:  2014-09-25       Impact factor: 17.970

7.  Specific interaction of the transcription elongation regulator TCERG1 with RNA polymerase II requires simultaneous phosphorylation at Ser2, Ser5, and Ser7 within the carboxyl-terminal domain repeat.

Authors:  Jiangxin Liu; Shilong Fan; Chul-Jin Lee; Arno L Greenleaf; Pei Zhou
Journal:  J Biol Chem       Date:  2013-02-22       Impact factor: 5.157

Review 8.  RNA Exosome Regulates AID DNA Mutator Activity in the B Cell Genome.

Authors:  Evangelos Pefanis; Uttiya Basu
Journal:  Adv Immunol       Date:  2015-05-14       Impact factor: 3.543

9.  CREPT serves as a biomarker of poor survival in pancreatic ductal adenocarcinoma.

Authors:  Gang Yang; Yicheng Wang; Jianchun Xiao; Fangyu Zhao; Jiangdong Qiu; Yueze Liu; Guangyu Chen; Zhe Cao; Lei You; Lianfang Zheng; Taiping Zhang; Yupei Zhao
Journal:  Cell Oncol (Dordr)       Date:  2020-10-30       Impact factor: 6.730

10.  The Mediator Subunit MED16 Transduces NRF2-Activating Signals into Antioxidant Gene Expression.

Authors:  Hiroki Sekine; Keito Okazaki; Nao Ota; Hiroki Shima; Yasutake Katoh; Norio Suzuki; Kazuhiko Igarashi; Mitsuhiro Ito; Hozumi Motohashi; Masayuki Yamamoto
Journal:  Mol Cell Biol       Date:  2015-11-16       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.